Published in BMJ Open on October 05, 2017
Research electronic data capture (REDCap)--a metadata-driven methodology and workflow process for providing translational research informatics support. J Biomed Inform (2008) 71.12
Pharmaceutical industry sponsorship and research outcome and quality: systematic review. BMJ (2003) 18.72
SPIRIT 2013 explanation and elaboration: guidance for protocols of clinical trials. BMJ (2013) 9.01
SPIRIT 2013 statement: defining standard protocol items for clinical trials. Ann Intern Med (2013) 8.21
Association of funding and conclusions in randomized drug trials: a reflection of treatment effect or adverse events? JAMA (2003) 8.21
The uncertainty principle and industry-sponsored research. Lancet (2000) 7.75
CONSORT 2010 Explanation and Elaboration: Updated guidelines for reporting parallel group randomised trials. J Clin Epidemiol (2010) 7.04
A randomized study of how physicians interpret research funding disclosures. N Engl J Med (2012) 5.47
A study of manufacturer-supported trials of nonsteroidal anti-inflammatory drugs in the treatment of arthritis. Arch Intern Med (1994) 5.04
Association between industry funding and statistically significant pro-industry findings in medical and surgical randomized trials. CMAJ (2004) 4.53
Preferred reporting items for systematic reviews and meta-analyses: the PRISMA Statement. Open Med (2009) 4.43
CONSORT 2010 Statement: Updated guidelines for reporting parallel group randomised trials. J Clin Epidemiol (2010) 3.96
Reported outcomes in major cardiovascular clinical trials funded by for-profit and not-for-profit organizations: 2000-2005. JAMA (2006) 3.65
Factors associated with findings of published trials of drug-drug comparisons: why some statins appear more efficacious than others. PLoS Med (2007) 2.36
Quality of reporting of randomized controlled trials in general endocrinology literature. J Clin Endocrinol Metab (2008) 2.24
The association between funding by commercial interests and study outcome in randomized controlled drug trials. Fam Pract (2001) 1.95
Funding source, trial outcome and reporting quality: are they related? Results of a pilot study. BMC Health Serv Res (2002) 1.93
The impact of pharmaceutical company funding on results of randomized trials of nicotine replacement therapy for smoking cessation: a meta-analysis. Addiction (2007) 1.92
Sugar Industry and Coronary Heart Disease Research: A Historical Analysis of Internal Industry Documents. JAMA Intern Med (2016) 1.71
Association between pharmaceutical involvement and outcomes in breast cancer clinical trials. Cancer (2007) 1.62
The quality of reporting of randomized controlled trials in solid organ transplantation. Transpl Int (2008) 1.46
Association between research sponsorship and study outcome in plastic surgery literature. Ann Plast Surg (2009) 1.45
Industry support and correlation to study outcome for papers published in Spine. Spine (Phila Pa 1976) (2005) 1.37
An analysis of the effect of funding source in randomized clinical trials of second generation antipsychotics for the treatment of schizophrenia. Control Clin Trials (2004) 1.22
Influence of drug company authorship and sponsorship on drug trial outcomes. Br J Psychiatry (2007) 1.20
Assessment of risk of bias among pediatric randomized controlled trials. Pediatrics (2010) 1.11
Impact, challenges, and future projections of vaccine trials in Africa. Am J Trop Med Hyg (2013) 1.10
Extent and impact of industry sponsorship conflicts of interest in dermatology research. J Am Acad Dermatol (2005) 1.09
A Systematic Review of Surgical Randomized Controlled Trials: Part 2. Funding Source, Conflict of Interest, and Sample Size in Plastic Surgery. Plast Reconstr Surg (2016) 1.08
Sponsors' participation in conduct and reporting of industry trials: a descriptive study. Trials (2012) 1.04
Financial disclosures of authors involved in spine research: an underestimated source of bias. Eur Spine J (2011) 1.02
Ethical considerations in the interpretation and communication of clinical trial results. Proc Am Thorac Soc (2007) 1.02
Association of industry funding with the outcome and quality of randomized controlled trials of drug therapy for rheumatoid arthritis. Arthritis Rheum (2012) 0.99
Does low-energy sweetener consumption affect energy intake and body weight? A systematic review, including meta-analyses, of the evidence from human and animal studies. Int J Obes (Lond) (2015) 0.96
Requirements of Clinical Journals for Authors' Disclosure of Financial and Non-Financial Conflicts of Interest: A Cross Sectional Study. PLoS One (2016) 0.92
Learning from past mistakes: assessing trial quality, power and eligibility in non-renal systemic lupus erythematosus randomized controlled trials. Rheumatology (Oxford) (2008) 0.91
How do authors of systematic reviews deal with research malpractice and misconduct in original studies? A cross-sectional analysis of systematic reviews and survey of their authors. BMJ Open (2016) 0.90
Sponsorship in non-commercial clinical trials: definitions, challenges and the role of Good Clinical Practices guidelines. BMC Int Health Hum Rights (2015) 0.89
Does source of funding and conflict of interest influence the outcome and quality of spinal research? Spine J (2013) 0.89
Disclosure of competing financial interests and role of sponsors in phase III cancer trials. Eur J Cancer (2005) 0.89
Association between funding source, methodological quality and research outcomes in randomized controlled trials of synbiotics, probiotics and prebiotics added to infant formula: a systematic review. BMC Med Res Methodol (2013) 0.87
Reporting, handling and assessing the risk of bias associated with missing participant data in systematic reviews: a methodological survey. BMJ Open (2015) 0.85
Industry sponsorship and research outcome. Cochrane Database Syst Rev (2017) 0.84
Agreements between Industry and Academia on Publication Rights: A Retrospective Study of Protocols and Publications of Randomized Clinical Trials. PLoS Med (2016) 0.82
Funding source and the quality of reports of chronic wounds trials: 2004 to 2011. Trials (2014) 0.79
Impact of Funding Source on Clinical Trial Results Including Cardiovascular Outcome Trials. Am J Cardiol (2015) 0.77
Authors of Clinical Trials Reported Individual and Financial Conflicts of Interest More Frequently than Institutional and non-financial Ones: a Methodological Survey. J Clin Epidemiol (2017) 0.76
Disclosure of funding sources and conflicts of interest in phase III surgical trials: survey of ten general surgery journals. World J Surg (2014) 0.76
Coca-Cola funded group set up to promote "energy balance" is disbanded. BMJ (2015) 0.76
Managing clinical grant costs. Contemp Clin Trials (2009) 0.76
Reporting of financial and non-financial conflicts of interest by authors of systematic reviews: a methodological survey. BMJ Open (2016) 0.75
Sponsorship of National Health Organizations by Two Major Soda Companies. Am J Prev Med (2016) 0.75
Pharmacists' views and reported practices in relation to a new generic drug substitution policy in Lebanon: a mixed methods study. Implement Sci (2017) 0.78
Shorter or longer anticoagulation to prevent recurrent venous thromboembolism: systematic review and meta-analysis. BMJ Open (2014) 0.75
Reporting of financial and non-financial conflicts of interest by authors of systematic reviews: a methodological survey. BMJ Open (2016) 0.75
Brazilian medicinal plants to treat upper respiratory tract and bronchial illness: systematic review and meta-analyses-study protocol. BMJ Open (2014) 0.75
Sex differences and adverse events of antiretrovirals in people living with HIV/AIDS: a systematic review and meta-analysis protocol. BMJ Open (2022) 0.75
Evidence on acupuncture therapies is underused in clinical practice and health policy. BMJ (2022) 0.75
Requirements of health policy and services journals for authors to disclose financial and non-financial conflicts of interest: a cross-sectional study. Health Res Policy Syst (2017) 0.75
Use of IMMPACT domains in clinical trials of acupuncture for chronic pain: a protocol for a methodological survey. BMJ Open (2017) 0.75